A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors
Clinical trial NCT02650713 · COMPLETED
Trial details
- NCT number
- NCT02650713
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-07
- Primary completion
- 2020-01-13
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.